Background Increasing evidence suggests that 1-dose human papillomavirus (HPV)
vaccination may protect significantly against HPV-related disease. We provide nationwide …

Background. Reducing the number of doses in the human papillomavirus (HPV) vaccination
regimen from 3 to 2 could increase coverage rates. In this cohort study, we assessed the risk …

Background. A reduction in the incidence of genital warts (GWs) is one of the first markers of
the effectiveness of vaccination against human papillomavirus (HPV) at the population level …

Background To assess the impact of a quadrivalent human papillomavirus vaccine (4HPV)
in women at increased risk of genital warts (GWs) acquisition. Methods The study was …

Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts (GW)
in women aged 14–23 years and to estimate the incidence of GW in the whole population …

Abstract Background In 2009, both Norway and Denmark initiated routine quadrivalent
human papillomavirus vaccination (qHPV) for 12-year-old girls; however, Denmark also …

Objective Genital warts are the most common sexually transmitted disease and have a
detrimental impact on quality of life. Genital warts could be prevented by prophylactic HPV …

Human papillomavirus (HPV) is the most prevalent sexually transmitted infection among
young women. Notably, more than ten years after the introduction of HPV vaccination …

Background. More than 90% of genital warts (GW) cases are caused by human
papillomavirus (HPV) types 6 and 11. The introduction of HPV vaccines necessitates the …

Background There is ongoing debate about the possible protective effect of the bivalent
human papillomavirus (2vHPV) vaccine, targeting oncogenic types HPV-16/18, against …